Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Smead Value C (SVFCX) Competitors

Smead Value C logo
$89.67 +0.29 (+0.32%)
As of 05/21/2026
Compare

SVFCX vs. ZI, APXT, MIXT, ULTI, and APCX

Should you buy Smead Value C stock or one of its competitors? MarketBeat compares Smead Value C with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Smead Value C include ZoomInfo Technologies (ZI), Apex Technology Acquisition (APXT), MiX Telematics (MIXT), REX IncomeMax Option Strategy ETF (ULTI), and AppTech Payments (APCX).

How does Smead Value C compare to ZoomInfo Technologies?

ZoomInfo Technologies (NASDAQ:ZI) and Smead Value C (NASDAQ:SVFCX) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

95.5% of ZoomInfo Technologies shares are held by institutional investors. Comparatively, 60.2% of Smead Value C shares are held by institutional investors. 9.0% of ZoomInfo Technologies shares are held by company insiders. Comparatively, 10.3% of Smead Value C shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

ZoomInfo Technologies has higher revenue and earnings than Smead Value C.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZoomInfo Technologies$1.21B1.02$107.30M$0.1230.08
Smead Value CN/AN/A-$6.48MN/AN/A

ZoomInfo Technologies has a net margin of 0.74% compared to Smead Value C's net margin of 0.00%. ZoomInfo Technologies' return on equity of 12.05% beat Smead Value C's return on equity.

Company Net Margins Return on Equity Return on Assets
ZoomInfo Technologies0.74% 12.05% 3.46%
Smead Value C N/A N/A -17.75%

In the previous week, ZoomInfo Technologies had 1 more articles in the media than Smead Value C. MarketBeat recorded 1 mentions for ZoomInfo Technologies and 0 mentions for Smead Value C. ZoomInfo Technologies' average media sentiment score of 0.28 beat Smead Value C's score of 0.00 indicating that ZoomInfo Technologies is being referred to more favorably in the media.

Company Overall Sentiment
ZoomInfo Technologies Neutral
Smead Value C Neutral

ZoomInfo Technologies currently has a consensus price target of $6.00, indicating a potential upside of 66.20%. Given ZoomInfo Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe ZoomInfo Technologies is more favorable than Smead Value C.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZoomInfo Technologies
2 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80
Smead Value C
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

ZoomInfo Technologies has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market.

Summary

ZoomInfo Technologies beats Smead Value C on 12 of the 13 factors compared between the two stocks.

How does Smead Value C compare to Apex Technology Acquisition?

Apex Technology Acquisition (NASDAQ:APXT) and Smead Value C (NASDAQ:SVFCX) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

In the previous week, Apex Technology Acquisition had 1 more articles in the media than Smead Value C. MarketBeat recorded 1 mentions for Apex Technology Acquisition and 0 mentions for Smead Value C. Smead Value C's average media sentiment score of 0.00 beat Apex Technology Acquisition's score of -0.63 indicating that Smead Value C is being referred to more favorably in the news media.

Company Overall Sentiment
Apex Technology Acquisition Negative
Smead Value C Neutral

Apex Technology Acquisition has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, suggesting that its share price is 89% less volatile than the broader market.

6.0% of Apex Technology Acquisition shares are owned by institutional investors. Comparatively, 60.2% of Smead Value C shares are owned by institutional investors. 21.1% of Apex Technology Acquisition shares are owned by insiders. Comparatively, 10.3% of Smead Value C shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apex Technology AcquisitionN/AN/A-$60.72MN/AN/A
Smead Value CN/AN/A-$6.48MN/AN/A

Smead Value C's return on equity of 0.00% beat Apex Technology Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Apex Technology AcquisitionN/A -750.42% -10.63%
Smead Value C N/A N/A -17.75%

Summary

Apex Technology Acquisition and Smead Value C tied by winning 4 of the 8 factors compared between the two stocks.

How does Smead Value C compare to MiX Telematics?

Smead Value C (NASDAQ:SVFCX) and MiX Telematics (NYSE:MIXT) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

MiX Telematics has a net margin of 3.72% compared to Smead Value C's net margin of 0.00%. MiX Telematics' return on equity of 8.45% beat Smead Value C's return on equity.

Company Net Margins Return on Equity Return on Assets
Smead Value CN/A N/A -17.75%
MiX Telematics 3.72%8.45%5.11%

In the previous week, Smead Value C's average media sentiment score of 0.00 equaled MiX Telematics'average media sentiment score.

Company Overall Sentiment
Smead Value C Neutral
MiX Telematics Neutral

MiX Telematics has higher revenue and earnings than Smead Value C.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smead Value CN/AN/A-$6.48MN/AN/A
MiX Telematics$150.06M2.36$4.52M$0.2558.20

60.2% of Smead Value C shares are owned by institutional investors. Comparatively, 45.7% of MiX Telematics shares are owned by institutional investors. 10.3% of Smead Value C shares are owned by company insiders. Comparatively, 12.4% of MiX Telematics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Smead Value C has a beta of 0.11, meaning that its share price is 89% less volatile than the broader market. Comparatively, MiX Telematics has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market.

Summary

MiX Telematics beats Smead Value C on 7 of the 8 factors compared between the two stocks.

How does Smead Value C compare to REX IncomeMax Option Strategy ETF?

REX IncomeMax Option Strategy ETF (NASDAQ:ULTI) and Smead Value C (NASDAQ:SVFCX) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

REX IncomeMax Option Strategy ETF has a net margin of 4.78% compared to Smead Value C's net margin of 0.00%. REX IncomeMax Option Strategy ETF's return on equity of 8.84% beat Smead Value C's return on equity.

Company Net Margins Return on Equity Return on Assets
REX IncomeMax Option Strategy ETF4.78% 8.84% 3.38%
Smead Value C N/A N/A -17.75%

In the previous week, REX IncomeMax Option Strategy ETF had 1 more articles in the media than Smead Value C. MarketBeat recorded 1 mentions for REX IncomeMax Option Strategy ETF and 0 mentions for Smead Value C. Smead Value C's average media sentiment score of 0.00 beat REX IncomeMax Option Strategy ETF's score of -2.00 indicating that Smead Value C is being referred to more favorably in the news media.

Company Overall Sentiment
REX IncomeMax Option Strategy ETF Very Negative
Smead Value C Neutral

REX IncomeMax Option Strategy ETF has higher revenue and earnings than Smead Value C.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
REX IncomeMax Option Strategy ETF$1.14B0.03$65.14M$2.077.11
Smead Value CN/AN/A-$6.48MN/AN/A

REX IncomeMax Option Strategy ETF currently has a consensus price target of $14.71, suggesting a potential upside of 0.00%. Given REX IncomeMax Option Strategy ETF's stronger consensus rating and higher possible upside, analysts clearly believe REX IncomeMax Option Strategy ETF is more favorable than Smead Value C.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
REX IncomeMax Option Strategy ETF
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.55
Smead Value C
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

REX IncomeMax Option Strategy ETF has a beta of 4.32, suggesting that its share price is 332% more volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, suggesting that its share price is 89% less volatile than the broader market.

91.2% of REX IncomeMax Option Strategy ETF shares are owned by institutional investors. Comparatively, 60.2% of Smead Value C shares are owned by institutional investors. 3.0% of REX IncomeMax Option Strategy ETF shares are owned by insiders. Comparatively, 10.3% of Smead Value C shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

REX IncomeMax Option Strategy ETF beats Smead Value C on 11 of the 13 factors compared between the two stocks.

How does Smead Value C compare to AppTech Payments?

AppTech Payments (NASDAQ:APCX) and Smead Value C (NASDAQ:SVFCX) are both prepackaged software industry companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Smead Value C has a net margin of 0.00% compared to AppTech Payments' net margin of -3,119.45%. Smead Value C's return on equity of 0.00% beat AppTech Payments' return on equity.

Company Net Margins Return on Equity Return on Assets
AppTech Payments-3,119.45% -398.98% -153.45%
Smead Value C N/A N/A -17.75%

In the previous week, AppTech Payments' average media sentiment score of 0.00 equaled Smead Value C'saverage media sentiment score.

Company Overall Sentiment
AppTech Payments Neutral
Smead Value C Neutral

AppTech Payments has a beta of -0.41, indicating that its share price is 141% less volatile than the broader market. Comparatively, Smead Value C has a beta of 0.11, indicating that its share price is 89% less volatile than the broader market.

5.2% of AppTech Payments shares are owned by institutional investors. Comparatively, 60.2% of Smead Value C shares are owned by institutional investors. 44.5% of AppTech Payments shares are owned by company insiders. Comparatively, 10.3% of Smead Value C shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Smead Value C has lower revenue, but higher earnings than AppTech Payments.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AppTech Payments$276K52.59-$18.51M-$0.23N/A
Smead Value CN/AN/A-$6.48MN/AN/A

Summary

Smead Value C beats AppTech Payments on 6 of the 8 factors compared between the two stocks.

Get Smead Value C News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVFCX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SVFCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVFCX vs. The Competition

Export
MetricSmead Value CPrepackaged Software IndustryComputer SectorNASDAQ Exchange
Market Cap$3.68B$7.76B$39.13B$12.32B
Dividend YieldN/A0.89%3.20%5.28%
P/E RatioN/A25.98170.4725.66
Price / SalesN/A5.42630.9398.41
Price / CashN/A35.1948.7256.67
Price / Book-59.7811.3010.537.14
Net Income-$6.48M$78.90M$1.07B$335.98M
7 Day PerformanceN/A0.22%3.48%3.56%
1 Month PerformanceN/A-4.79%6.25%2.54%
1 Year PerformanceN/A538.88%169.78%35.05%

Smead Value C Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVFCX
Smead Value C
N/A$89.67
+0.3%		N/AN/A$3.68BN/AN/A2
ZI
ZoomInfo Technologies
2.6215 of 5 stars		$3.92
+1.6%		$12.00
+206.1%		-61.9%$1.34B$1.21B130.713,540
APXT
Apex Technology Acquisition
0.4829 of 5 stars		$10.01
flat		N/A-45.0%$446.05MN/AN/AN/A
MIXT
MiX Telematics
N/A$14.55
flat		N/AN/A$353.75M$150.06M58.201,080
ULTI
REX IncomeMax Option Strategy ETF
N/A$12.65
-1.2%		N/AN/A$25.30M$1.14B6.115,162

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SVFCX) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel